Veozah, new menopause drug for hot flashes, wins FDA approval

Veozah, new menopause drug for hot flashes, wins FDA approval

There may be relief for women who suffer through hot flashes, night sweats, chills and other symptoms of menopause.  The Food and Drug Administration approved a new drug called Veozah (generic name: fezolinetant), which is a one-of-a-kind treatment for menopause symptoms. As a non-hormonal drug, it’s a boon for women who cannot use hormone-replacement therapy … Read more

Fox got Alex Rodriguez’s approval before hiring Derek Jeter on MLB pregame show

Fox got Alex Rodriguez’s approval before hiring Derek Jeter on MLB pregame show

Before Fox Sports CEO Eric Shanks agreed to go through with signing Derek Jeter for the network’s top MLB pregame show, he reached out to Jeter’s longtime frenemy and Fox Sports analyst Alex Rodriguez to get the green light, The Post has learned. A-Rod gave Jeter the thumbs up and now Rodriguez will be teammates … Read more

Pfizer migraine nasal spray snags FDA approval for summer launch

Pfizer migraine nasal spray snags FDA approval for summer launch

People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide (CGRP) receptor antagonist nasal spray intended to treat migraines in adults.  Pfizer produces the medication, called Zavzpret. It works by blocking CGRPs, a … Read more

Breakthrough Alzheimer’s drug earns accelerated FDA approval

Breakthrough Alzheimer’s drug earns accelerated FDA approval

A new, breakthrough drug designed to aggressively treat Alzheimer’s disease was awarded accelerated approval by the Food and Drug Administration on Friday. Leqembi — developed by Tokyo-headquartered Eisai — has been shown in trials to slow the cognitive and functional decline of people in the early stages of the illness. The accelerated approval comes amid … Read more

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval

Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval

A much-debated drug for Lou Gehrig’s disease won US approval on Thursday from the Food and Drug Administration. The nod represents a long-desired victory for patients, though it is likely to renew questions about the scientific rigor behind government reviews of experimental medicines, as the Associated Press has reported.  The FDA approved the drug from Amylyx Pharmaceuticals based … Read more